Zota Health Care LImited — Important, 17-03-2025: Updates

Zota Health Care Limited has received a product registration license for its antibiotic, AZITOZ 500, from the Ministry of Health in Cambodia. The license is valid for five years, with the possibility of renewal. The company plans to commence exports of this product to Cambodia in the near term. This development opens new market opportunities for Zota Health Care, enhancing its international presence and potentially boosting revenue streams. Investors should watch closely for subsequent updates related to market entry and performance metrics in the new region.